Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

799 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment.
Evans DG, Phillips KA, Milne RL, Fruscio R, Cybulski C, Gronwald J, Lubinski J, Huzarski T, Hyder Z, Forde C, Metcalfe K, Senter L, Weitzel J, Tung N, Zakalik D, Ekholm M, Sun P, Narod SA; kConFab Investigators, Polish Hereditary Breast Cancer Consortium, Hereditary Breast Cancer Clinical Study Group. Evans DG, et al. Among authors: phillips ka. Br J Cancer. 2023 Feb;128(4):703. doi: 10.1038/s41416-022-02130-9. Br J Cancer. 2023. PMID: 36639528 Free PMC article. No abstract available.
Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry.
Chang ET, Milne RL, Phillips KA, Figueiredo JC, Sangaramoorthy M, Keegan TH, Andrulis IL, Hopper JL, Goodwin PJ, O'Malley FP, Weerasooriya N, Apicella C, Southey MC, Friedlander ML, Giles GG, Whittemore AS, West DW, John EM. Chang ET, et al. Among authors: phillips ka. Breast Cancer Res Treat. 2009 Sep;117(1):167-76. doi: 10.1007/s10549-008-0255-3. Epub 2008 Nov 26. Breast Cancer Res Treat. 2009. PMID: 19034644 Free PMC article.
Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry.
Phillips KA, Milne RL, West DW, Goodwin PJ, Giles GG, Chang ET, Figueiredo JC, Friedlander ML, Keegan TH, Glendon G, Apicella C, O'Malley FP, Southey MC, Andrulis IL, John EM, Hopper JL. Phillips KA, et al. Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1792-7. doi: 10.1158/1055-9965.EPI-08-1014. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19505912 Free PMC article.
Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).
Kiely BE, Jenkins MA, McKinley JM, Friedlander ML, Weideman P, Milne RL, McLachlan SA, Hopper JL, Phillips KA. Kiely BE, et al. Among authors: phillips ka. Breast Cancer Res Treat. 2010 Apr;120(3):715-23. doi: 10.1007/s10549-009-0497-8. Epub 2009 Aug 11. Breast Cancer Res Treat. 2010. PMID: 19669874
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers.
McKinley JM, Weideman PC, Jenkins MA, Friedlander ML, Hopper JL, McLachlan SA, Lindeman GJ; Investigators KConFab; Phillips KA. McKinley JM, et al. Among authors: phillips ka. Hered Cancer Clin Pract. 2007 Sep 15;5(3):161-3. doi: 10.1186/1897-4287-5-3-161. Hered Cancer Clin Pract. 2007. PMID: 19725993 Free PMC article.
Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.
Goodwin PJ, Phillips KA, West DW, Ennis M, Hopper JL, John EM, O'Malley FP, Milne RL, Andrulis IL, Friedlander ML, Southey MC, Apicella C, Giles GG, Longacre TA. Goodwin PJ, et al. Among authors: phillips ka. J Clin Oncol. 2012 Jan 1;30(1):19-26. doi: 10.1200/JCO.2010.33.0068. Epub 2011 Dec 5. J Clin Oncol. 2012. PMID: 22147742
Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.
Phillips KA, Milne RL, Rookus MA, Daly MB, Antoniou AC, Peock S, Frost D, Easton DF, Ellis S, Friedlander ML, Buys SS, Andrieu N, Noguès C, Stoppa-Lyonnet D, Bonadona V, Pujol P, McLachlan SA, John EM, Hooning MJ, Seynaeve C, Tollenaar RA, Goldgar DE, Terry MB, Caldes T, Weideman PC, Andrulis IL, Singer CF, Birch K, Simard J, Southey MC, Olsson HL, Jakubowska A, Olah E, Gerdes AM, Foretova L, Hopper JL. Phillips KA, et al. J Clin Oncol. 2013 Sep 1;31(25):3091-9. doi: 10.1200/JCO.2012.47.8313. Epub 2013 Aug 5. J Clin Oncol. 2013. PMID: 23918944 Free PMC article.
Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.
Collins IM, Milne RL, McLachlan SA, Friedlander M, Hickey M, Weideman PC, Birch KE, Hopper JL, Phillips KA. Collins IM, et al. Among authors: phillips ka. J Clin Oncol. 2013 Nov 1;31(31):3920-5. doi: 10.1200/JCO.2013.49.3007. Epub 2013 Sep 30. J Clin Oncol. 2013. PMID: 24081944
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.
Collins IM, Milne RL, Weideman PC, McLachlan SA, Friedlander ML; Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer; Hopper JL, Phillips KA. Collins IM, et al. Among authors: phillips ka. Med J Aust. 2013 Nov 18;199(10):680-3. doi: 10.5694/mja13.10848. Med J Aust. 2013. PMID: 24237098
799 results